双[2-(二-叔丁基膦基)乙基]胺

  • 基本信息
  • MSDS

双[2-(二-叔丁基膦基)乙基]胺 基本信息

中文名称:
双[2-(二-叔丁基膦基)乙基]胺 
中文别名:
 
英文名称:
Bis[2-(di-t-butylphosphino)ethyl]amine, min. 97%
英文别名:
2-ditert-butylphosphanyl-N-(2-ditert-butylphosphanylethyl)ethanamine;
BIS[2-(DI-T-BUTYLPHOSPHINO)ETHYL]AMINE;
BIS[2-(DI-TERT-BUTYLPHOSPHINO)ETHYL]AMINE 
CAS No.:
944710-34-3
分 子 式:
C20H45NP2
分 子 量:
361.525522
精确分子量:
361.30300
PSA:
39.21000
分子结构式:
SDS:
查看

双[2-(二-叔丁基膦基)乙基]胺 MSDS


Section 1: Product Identification
   Chemical Name:       Bis[2-(di-t-butylphosphino)ethyl]amine, min. 97% (10wt% in hexanes)    
   CAS Registry Number:       944710-34-3    
   Formula:       C20H45NP2    
   EINECS Number:       none    
   Chemical Family:       organophosphine ligand    
   Synonym:       none    

Section 2: Composition and Information on Ingredients
   Ingredient       CAS Number       Percent       ACGIH (TWA)       OSHA (PEL)    
   Title compound       944710-34-3       10%       no data       no data    
   Hexane       73513-42-5       90%       50ppm       1800mg/m3    

Section 3: Hazards Identification
   Extremely flammable liquid. Vapors irritating to skin, eyes and respiratory tract. Inhalation of vapors may
   Emergency Overview:
   depress central nervous system causing dizziness, headache and nausea.
   Primary Routes of Exposure:       Ingestion, inhalation    
   Eye Contact:       Contact will cause irritation, redness and a burning sensation.    
   Skin Contact:       Contact with skin can result in local irritation. May be absorbed through skin.    
   Inhalation of vapors may depress the central nervous system causing dizziness, difficulty in walking and
   Inhalation:
   irritation to the lungs.
   Ingestion may cause gastrointestinal irritation, nausea, vomiting and headache. May cause lung damage if
   Ingestion:
   swallowed.
   Irritating to skin, eyes and respiratory tract. Harmful by inhalation. Ingestion may cause gastrointestinal
   Acute Health Affects:
   irritation, nausea, vomiting and headache. Possible risk of harm to the unborn child.
   Chronic Health Affects:       No information on long-term chronic effects. Possible risk of impaired fertility.    
   NTP:       No    
   IARC:       No    
   OSHA:       No    

SECTION 4: First Aid Measures
   Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
   Eye Exposure:
   assistance in keeping their eye lids open. Get immediate medical attention.
   Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
   Skin Exposure:
   irritation persists.
   Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
   Inhalation:
   in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
   Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
   Ingestion:
   vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
   Flash Point:       -14.8°F (hexane)    
   Autoignition Temperature:       no data    
   Explosion Limits:       LEL(1.7%) UEL(7.7%) hexane    
   Extinguishing Medium:       carbon dioxide, dry powder or foam    
   If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
   Special Fire Fighting Procedures:
   self-contained breathing apparatus and full protective clothing.
   Hazardous Combustion and       If involved in a fire this material may emit toxic and irritating fumes.    
   Decomposion Products:
   Unusual Fire or Explosion Hazards: Highly flammable. Vapors can form explosive mixtures in air.

SECTION 6: Accidental Release Measures
   If spilled, all personnel must be immediately evacuated and the area sealed off. The material may self-ignite
   Spill and Leak Procedures:       releasing toxic and corrosive fumes of phosphorus pentoxide. Ventilation should be available. If entry into the    
   area is required, personnel should be fitted with a self-contained breathing apparatus.

SECTION 7: Handling and Storage
   Store in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep away from heat.
   Handling and Storage:
   Material should be transferred under an inert atmosphere of nitrogen or argon in an efficient fume hood.

SECTION 8: Exposure Controls and Personal Protection
   Eye Protection:       Always wear approved safety glasses when handling a chemical substance in the laboratory.    
   Skin Protection:       Wear protective clothing and gloves.    
   Ventilation:       Handle the material in an efficient fume hood.    
   If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
   Respirator:
   Protection Program to be in compliance with 29 CFR 1910.134.
   Ventilation:       Handle the material in an efficient fume hood.    
   Additional Protection:       No additional protection required.    

SECTION 9: Physical and Chemical Properties
   Color and Form:       colorless liquid    
   Molecular Weight:       361.53    
   Melting Point:       no data    
   Boiling Point:       68°C (hexane)    
   Vapor Pressure:       no data    
   Specific Gravity:       no data    
   Odor:       pungent and noxious    
   Solubility in Water:       insoluble    

SECTION 10: Stability and Reactivity
   Stability:       air sensitive    
   Hazardous Polymerization:       no hazardous polymerization    
   Conditions to Avoid:       contact with oxidizing agents, ignition sources and prolonged exposure to air    
   Incompatibility:       strong oxidizing agents and halogens    
   Decomposition Products:       carbon monoxide, carbon dioxide, phosphorous oxides and organic fumes    

SECTION 11: Toxicological Information
   Title compound: No information available in the RTECS files. Hexane: Inhalation(humane); TCLo:
   190ppm/8W. Inhalation(rat); LC50: 48000ppm/4H. Intraperitoneal(rat); LDLo: 9100mg/kg. Inhalation(mouse);
   LCLo: 120g/m3. Intravenous(mouse); LDLo: 831mg/kg. Intravenous(rabbit); LDLo: 132mg/kg. Oral(rat); TDLo:
   RTECS Data:
   20000mg/kg. Oral(rat); LD50: 15840mg/kg. Inhalation(rat); TCLo: 1000ppm/4H/59W
   (intermittent)-Tumorigenic-carcinogenic by RTECS criteria. Inhalation(rat); TCLo: 10000ppm/7H; female-1-18
   days after conception-behavorial effects on newborn.
   Carcinogenic Effects:       Hexane: Insufficient data    
   Mutagenic Effects:       Hexane: Possible mutagen    
   Tetratogenic Effects:       Hexane: Possible reproductive effector    

SECTION 12: Ecological Information
   Hexane is very toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment.
   Ecological Information:
   Avoid release to the environment.

SECTION 13: Disposal Considerations
   Disposal:       Dispose of according to local, state and federal regulations.    

SECTION 14: Transportation
   Shipping Name (CFR):       Flammable liquids, N.O.S.    
   Hazard Class (CFR):       3    
   Additional Hazard Class (CFR):       NA    
   Packaging Group (CFR):       I    
   UN ID Number (CFR):       UN# 1993    
   Shipping Name (IATA):       Flammable liquid, N.O.S.    
   Hazard Class (IATA):       3    
   Additional Hazard Class (IATA):       NA    
   Packaging Group (IATA):       I    
   UN ID Number (IATA):       UN# 1993    

SECTION 15: Regulatory Information
   TSCA:       Not listed in the TSCA inventory    
   SARA (Title 313):       Not reportable under SARA 313.    
   Second Ingredient:       Hexane: Listed in the TSCA inventory. Reportable under SARA 313.    


SECTION 16 - ADDITIONAL INFORMATION
N/A

推荐供应商更多供应商>>